2023 EANM Annual Meeting

9-13 September 2023, Vienna

Delegates: Ruth Devenyns (CEO), Dimitrios Mantzilas (CTO), Josie Gayton (CDO), Matthias D'Huyvetter (Science Director), Stéphanie Put (Head of Corporate Development)

Preclinical Team Leader, Yana Dekempeneer, will present

"Preclinical evaluation of a radiotheranostic single-domain antibody against Fibroblast Activation Protein alpha"

Session 1509 - Tuesday, September 12, 2023 | 15:00 – 16:30 | Hall G2